Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced ...

Q4 2024 Management View CEO Mark Newcomer highlighted that Paysign achieved exceptional growth in its patient affordability business in 2024, with annual revenue increasing by 212% to $12.7 million.

The fourth edition of PoliChemistryFEST, an event dedicated to innovations and new trends in the fields of chemistry, ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

The healthcare industry is experiencing a significant shift with the integration of digital innovations in cold chain ...

On 'The Adam Carolla Show' podcast, healthcare industry watchdog and wellness expert Calley Means shares why he believes the left used to question pharmaceutical companies, big institutions, and war ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Women’s health remains chronically underfunded, yet closing the gap could unlock a trillion-dollar economic opportunity.

Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the ...

The biopharma industry's return on investment in innovation is increasing, but R&D costs are rising, according to a new ...

President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...